Press Release | Sep 26, 2019

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce the closing of the acquisition of Achieve TMS Centers, LLC and Achieve TMS Alaska, LLC (collectively, “Achieve TMS”), as previously announced on September 11, 2019 (the “Acquisition”). The initial purchase price for Achieve TMS was US$10.5 million, net of Achieve TMS’ cash

Press Release | Sep 26, 2019

The new VSP Orthopaedics solution is available exclusively through Onkos Surgical’s My3D™ Personalized Solutions Platform and enables surgeons to devise a precise plan for tumor resection that in some cases allows for the preservation of the native joint. Virtual surgical planning of the patient’s 3D anatomy, allows the surgeon to essentially perform the surgery digitally

Press Release | Sep 11, 2019

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), the market leader in Transcranial Magnetic Stimulation (“TMS”) in the United States, announced today that it has, through its wholly-owned subsidiary TMS NeuroHealth Centers Inc., entered into a purchase agreement pursuant to which Greenbrook will acquire Achieve TMS Centers, LLC and Achieve TMS Alaska, LLC (collectively,

Press Release | Aug 28, 2019

Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regeneration. Onkos intends to distribute and market the products under the GenVie™ brand name.

Uncategorized | Aug 09, 2019

The second quarter of 2019 was very busy for Innovative Health LLC, as more EP labs are signing up and increasing their savings. We also expanded our portfolio of reprocessable devices significantly, opening the door for more savings. Read our newsletter here.

Press Release | Aug 06, 2019

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its second quarter 2019 operational and financial results. For more information, please refer to the Management’s Discussion & Analysis of Financial Condition and Results of Operations (“MD&A”) and the unaudited condensed interim consolidated financial statements of the Company for the three and six months

Pages 1 2 3 4 5 6 7 13